Results: 6

Unexpected improvement of hyperhidrosis with cannabidiol

ABSTRACT Hyperhidrosis is characterized by excessive sweating and it affects almost 5% of the population. The affected age group is wide, and it can affect from children to elderlies. There are two types of hyperhidrosis: generalized and focal. Treatment depends on the symptoms presented. In more severe ...

Calidad de vida luego de simpaticotomía toracoscópica por hiperhidrosis focal primaria

Rev. argent. cir; 113 (4), 2021
RESUMEN Antecedentes: la simpaticotomía toracoscópica demostró ser una cirugía segura para el tratamiento de la hiperhidrosis focal primaria (HFP); sin embargo, la calidad de vida no es totalmente satisfactoria en algunos pacientes, teniendo en cuenta la sudoración compensatoria como principal efec...

Symptoms of anxiety and depression in patients with primary hyperhidrosis and its association with the result of clinical treatment with oxybutynin

Clinics; 76 (), 2021
OBJECTIVES: Studies have identified correlations between the psychological characteristics of individuals with primary hyperhidrosis (HH), the degree of sweating, and the quality of life (QoL). This study aimed to evaluate the prevalence of anxiety and depression symptoms in patients with HH before and a...

Combination of topical agents and oxybutynin as a therapeutic modality for patients with both osmidrosis and hyperhidrosis

Summary Introduction: The association of osmidrosis and hyperhidrosis often causes emotional and social problems that may impair the patients' quality of life. The purpose of our study was to analyze the therapeutic results of oxybutynin and topical agents in 89 patients with both osmidrosis and hyperhi...

Oxybutynin as an alternative treatment for hyperhidrosis

An. bras. dermatol; 92 (2), 2017
Abstract: Hyperhidrosis is the excessive production of sweating, which can be primary and focal or secondary to various pathologies. The exact cause of primary focal hyperhidrosis is still unknown, although a genetic basis is recognized, and its prevalence varies from 1% to 2.8%. The most affected sites ...

Inyección intramuscular de toxina botulínica con fines dermocosmiátricos
Intramuscular injection of botulin toxin for dermocosmetic use

Rev. chil. dermatol; 15 (1), 1999
La toxina botulínica producida por el Clostridium botulinum es un potente inhibidor neuromuscular local, altamente específico, que actúa mediante bloqueo de la liberación de acetilcolina en la placa neuromuscular, traduciéndose clínicamente en una parálisis fláccida del músculo tratado. El uso d...